HomeRLYB • NASDAQ
add
Rallybio Corp
Previous close
$0.25
Day range
$0.22 - $0.28
Year range
$0.22 - $2.01
Market cap
11.26M USD
Avg Volume
131.87K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 38.00K | — |
Operating expense | 4.26M | -17.87% |
Net income | -11.04M | 45.44% |
Net profit margin | -29.06K | — |
Earnings per share | -0.25 | 50.00% |
EBITDA | -11.58M | 45.07% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 65.51M | -40.41% |
Total assets | 68.11M | -41.09% |
Total liabilities | 6.45M | -31.60% |
Total equity | 61.65M | — |
Shares outstanding | 41.61M | — |
Price to book | 0.17 | — |
Return on assets | -39.45% | — |
Return on capital | -43.69% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -11.04M | 45.44% |
Cash from operations | -9.86M | 15.31% |
Cash from investing | -1.57M | -109.30% |
Cash from financing | 18.00K | -75.00% |
Net change in cash | -11.42M | -313.96% |
Free cash flow | -6.37M | -38.97% |
About
Founded
2018
Headquarters
Website
Employees
25
